ReviewCureus2026
Closed-Loop Neuroprosthetics: Advancing Long-Term Solutions for Brain-Level Function Restoration.
Review in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Closed-loop neuroprosthetic devices use neural sensing coupled to real-time computational processing, feedback, and output applications to restore lost motor, sensory, or communication abilities. Despite having great potential, these devices have yet to make it into clinical practice due to unstable interfaces with the nervous system, where material fatigue, electrode degradation, inflammation, electrical drift, and other factors emerge over time to inhibit reliable sensor feedback and stimulation. This paper explores how these challenges grow exponentially at the cerebral level, where soft tissue, dense circuitry, and stochastic neuronal firing create significant hurdles to long-term implantation and recalibration. The author suggests that two lines of device development are slowly coming together: self-healing, deformable, and compliant interface materials that aim to maintain electrical coupling and adaptive control architectures that adjust decoding and feedback as biological conditions shift over time. By establishing the current neuroprosthetic implementations, persistent engineering challenges, and new design approaches, this paper presents a framework for neuroprosthetic devices that restore responsive function rather than provide short-term substitution.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.